Trial, The

Trial, The

novel of individual accused of crime by impersonal bureaucracy. [Ger. Lit.: The Trial]

Trial, The

Joseph K. is tried by a strange court for an unspecified crime. [Ger. Lit.: Kafka The Trial]
See: Trial
References in classic literature ?
When the Stranger with a Club was brought to trial, the complainant said to the Judge:
But, though the Doctor tried hard, and never ceased trying, to get Charles Darnay set at liberty, or at least to get him brought to trial, the public current of the time set too strong and fast for him.
The group that objected to the trial, the Women's Network for Unity, "was established in June 2000 by a group of sex workers for sex workers," and says it has 5,000 members in Cambodia.
Moreover, if the claim goes to trial, the decision whether to move forward or settle must be re-evaluated constantly in the face of new evidence and analysis.
While the patient may not benefit directly from the clinical trial, the data regarding the safety and effectiveness generated during the study will certainly benefit future generations of patients, and will serve society as a whole.
At the end of the trial, the court will be left with a morass of documents and testimony that it will be forced to pick through to identify for itself the issues and facts properly in dispute.
In this trial, the primary efficacy endpoint is change from baseline in FEV1 (liters) at the 24-week time point.
Based on the strength of the statistical results in the RAMP-1 trial, we feel confident that we have enrolled enough patients in our second Phase 3 trial, the RAMP-2 trial, which we have now completed.
Certain statements in this release are forward-looking and may involve risks and uncertainties, including statements with respect to the expected ability of the Company's brain assessment technology to predict the effectiveness of antidepressant medications, the anticipated outcomes and benefits of the BRITE trial, the Company's ability to successfully develop tools for the diagnosis and treatment of neurological diseases, such as depression and Alzheimer's disease and the benefits of such tools, if developed, for the general population of patients with such diseases.
Before formally completing either the 32 or 33 trial, the Company has elected to have an independent data monitoring board review the trial data and confirm that the number of patients currently enrolled will provide statistically significant information.
These risks and uncertainties include, among others, the timing of events in the RCC trial, the results of clinical trials, decisions by regulatory agencies, the cost of additional clinical trials, the outcome of process and preclinical development activities, the ability to raise additional capital, and the factors described under Factors That May Impact Future Results in the Management's Discussion and Analysis of Financial Condition and Results of Operations section of Antigenics' Form 10-Q as filed with the Securities and Exchange Commission on November 4, 2005.
Timothy Craig, DO, Professor of Medicine and Pediatrics at Penn State University and an investigator for the EDEMA2 trial, the interim data support that DX-88 can provide substantial therapeutic benefit to HAE patients, with no apparent decrease in drug effect in patients exposed to multiple doses.